Clinical trials in Kyrgyzstan
70 studies list at least one site in Kyrgyzstan. 10 are recruiting or about to start. Per ClinicalTrials.gov, last updated 2026-10-14.
Get an email when these change. Save the studies in Kyrgyzstan recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Most studied here
Who runs them
University of Zurich (39) · Yale University (4) · Bayer (3) · Eastern Switzerland University of Applied Sciences (3) · Kyrgyz State Medical Academy (2) · Rigshospitalet, Denmark (2) · Population Health Research Institute (2) · National Center of Cardiology and Internal Medicine named after academician M.Mirrakhimov (2)
Studies
Recruiting first, then most recently updated. Showing 50 of 70 — search for more.
- Expanding Medication-Assisted Therapies in Central AsiaRecruitingNCT05579470Not applicable
- CHROnic Migraine EmbolizationRecruitingNCT06848166Not applicable
- PRIDE III Prison Interventions and HIV Prevention CollaborationRecruitingNCT06962033Not applicable
- Integrating Evidence-based Approaches to Prevent Child Maltreatment in KyrgyzstanRecruitingNCT07712822Not applicable
- Lower Intersecting HIV-related Stigmas to Facilitate Treatment as Prevention (LIFT)Enrolling by invitationNCT07541131Not applicable
- CRP and Patient Information Leaflets to Optimise Antibiotic Treatments for Adults With Respiratory Tract Infections in Primary Care in KyrgyzstanRecruitingNCT07261969Not applicable
- HighCycle Study: Acetazolamide, High Altitude and Plasma VolumeRecruitingNCT07118462Phase 4
- Vacuum-assisted Laser Ablation (VALA) for Treatment of Large Saphenous VeinsRecruitingNCT06971068Not applicable
- Prospective Urban Rural Epidemiology StudyRecruitingNCT03225586
- Childhood Acute Lymphoblastic Leukemia Treatment Protocol Moscow-Berlin 2015 (ALL-MB 2015)RecruitingNCT03390387Not applicable
- Effect of Rehabilitation on the Respiratory Signal in Patients With COPD and Exercise-Induced DesaturationCompletedNCT07107828Not applicable
- Effect of Rehabilitation at Moderate Altitude on Airway Resistance Measured With Forced Oscillation Technique in COPD-patientsCompletedNCT07063563Not applicable
- Oxygen Therapy During Exercise Training in Inpatient Rehabilitation in Chronic Lung Disease- Does it Matter?CompletedNCT07044843Not applicable
- HighCycle Study: Effect of High Altitude on Acute Mountain Sickness in Women Related to Their Menstrual Cycle PhaseCompletedNCT06499714
- HighCycle Study: Effect of High Altitude on Sleep Disordered Breathing in Women Related to Their Menstrual Cycle PhaseCompletedNCT06498544
- HighCycle: Effect of Acetazolamide on Pulmonary Artery Pressure in Women Compared to MenCompletedNCT06498505Phase 4
- HighCycle Study: Effect of Acetazolamide on Sleep Disordered Breathing in Women Compared to MenCompletedNCT06498531Phase 4
- HighCycle Study: Effect of Acetazolamide on Acute Mountain Sickness in Women Compared to MenCompletedNCT06499727Phase 4
- High Altitude Residents With High Altitude Pulmonary Hypertension (HAPH), 6MWT Assessed at High Altitude (3200m) vs Low Altitude (760m)CompletedNCT06489691Not applicable
- High Altitude Residents With High Altitude Pulmonary Hypertension (HAPH), SDB Assessed at HA (3200 m) vs LA (760 m)CompletedNCT06489717Not applicable
- Highlanders With High Altitude Pulmonary Hypertension (HAPH), 6 Minute Walk Distance (6MWD) Assessed at 3200m With and Without Supplemental Oxygen Therapy (SOT)CompletedNCT06489743Not applicable
- High Altitude (HA) Residents With High Altitude Pulmonary Hypertension (HAPH), Pulmonary Artery Pressure (PAP) Assessed at HA (3200 m) vs LA (760 m)CompletedNCT06489704Not applicable
- Highlanders With High Altitude Pulmonary Hypertension (HAPH), Pulmonary Arterial Pressure (PAP) Assessed at 3200m With and Without Supplemental Oxygen Therapy (SOT)CompletedNCT06489756Not applicable
- Treatment Trial of Alveolar EchinococcosisCompletedNCT07182305Phase 2
- Compare the Quality of Life of Patients With Achalasia Cardia (AC) After Laparoscopic and Open Esophagocardiomyotomy.CompletedNCT07177222
- Project MATLINK: Development and Evaluation of a Screening, Brief Intervention, & Referral to Treatment (SBIRT) Program for Opioid Dependent Prisoners and Probationers Transitioning to the CommunityCompletedNCT04947475Not applicable
- Exploring the Feasibility of a Peer-Driven Intervention to Improve HIV Prevention Among Prisoners Who Inject DrugsCompletedNCT05786027Not applicable
- CRP for Respiratory Diagnosis in Kyrgyz Pediatric PracticeCompletedNCT05195866Not applicable
- Effect of Acetazolamide on Right Heart Function at Rest in Lowlanders Older Than 40 Years at Altitude.Status unknownNCT03540914Phase 4
- Acetazolamide to Prevent Impending Altitude-illness in Patients With COPDStatus unknownNCT04913389Phase 3
- Early Signs of Altitude Illness in Patients With COPDCompletedNCT03957759
- Effect of Acetazolamide on Right Heart Function During Exercise in Lowlanders Older Than 40 Years at AltitudeStatus unknownNCT03537924Phase 4
- Effect of Acetazolamide on Right Heart Function at Rest in Lowlanders With COPD Traveling to High AltitudeStatus unknownNCT04915365Phase 3
- Effect of Acetazolamide on Lung Water Content by Ultrasound in Lowlanders Older Than 40 Years at AltitudeStatus unknownNCT03539367Phase 4
- INVestIgation of rheumatiC AF Treatment Using Vitamin K Antagonists, Rivaroxaban or Aspirin Studies, Non-InferiorityCompletedNCT02832544Phase 3
- Hypoxia-altitude Testing to Predict Altitude Related Adverse Health Effects in Chronic Obstructive Pulmonary Disease (COPD) PatientsCompletedNCT04915378
- Expand New Drugs for TB [endTB]CompletedNCT03259269
- FS-1 Drug for Treatment of Multiple Drug-resistant TuberculosisCompletedNCT02607449Phase 3
- Effects of Remote Monitoring of Patients With Heart Failure Based on Smartphone ApplicationStatus unknownNCT04591964Early Phase 1
- Treatment and Companion Diagnostics of Lower Back Pain Using SCENAR and Passive Medical Radiometry (MWR)CompletedNCT05223946Not applicable
- Effect of Acetazolamide on Sleep Disordered Breathing in Lowlanders Older Than 40 Years at AltitudeCompletedNCT03536507Phase 4
- Effect of Acetazolamide on Lung Water Content by Ultrasound in Patients With Respiratory Disease at AltitudeCompletedNCT03540901Phase 4
- Effect of Acetazolamide on Postural Control in Patients With Respiratory Disease at AltitudeCompletedNCT03177811Phase 4
- Effect of Acetazolamide on Maximal Exercise Performance in Lowlanders Older Than 40 Years at AltitudeCompletedNCT03536455Phase 4
- Effect of Acetazolamide on Postural Control in Lowlanders Older Than 40 Years at AltitudeCompletedNCT03536429Phase 4
- Effect of Acetazolamide on Visuo-motor Learning in Lowlanders Older Than 40 Years at AltitudeCompletedNCT03536520Phase 4
- A Study Investigating Routine Practice of Chronic Thromboembolic Pulmonary Hypertension Management in EMEA CountriesCompletedNCT02637050
- Effect of Acetazolamide on Acute Mountain Sickness in Lowlanders Older Than 40 YearsCompletedNCT03561675Phase 4
- Helicobacter Pylori Genome Project (HpGP)TerminatedNCT02788214
- Passive Microwave Radiometry (MWR) and AI for COVID-19 Complications Early Diagnostics of LungsCompletedNCT04568525Not applicable